GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » EPS (Diluted)

PharmaTher Holdings (XCNQ:PHRM) EPS (Diluted) : C$-0.05 (TTM As of Feb. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings EPS (Diluted)?

PharmaTher Holdings's Earnings per Share (Diluted) for the three months ended in Feb. 2024 was C$-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.05.

PharmaTher Holdings's EPS (Basic) for the three months ended in Feb. 2024 was C$-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.05.

PharmaTher Holdings's EPS without NRI for the three months ended in Feb. 2024 was C$-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.05.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


PharmaTher Holdings EPS (Diluted) Historical Data

The historical data trend for PharmaTher Holdings's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings EPS (Diluted) Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
EPS (Diluted)
0.04 -0.05 -0.07

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.02 -0.02 -0.01 -

Competitive Comparison of PharmaTher Holdings's EPS (Diluted)

For the Biotechnology subindustry, PharmaTher Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaTher Holdings's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's PE Ratio falls into.



PharmaTher Holdings EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

PharmaTher Holdings's Diluted EPS for the fiscal year that ended in May. 2023 is calculated as

Diluted EPS (A: May. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-6.416-0)/88.169
=-0.07

PharmaTher Holdings's Diluted EPS for the quarter that ended in Feb. 2024 is calculated as

Diluted EPS (Q: Feb. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.363-0)/88.169
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaTher Holdings  (XCNQ:PHRM) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


PharmaTher Holdings EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings (XCNQ:PHRM) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines